Latest AstraZeneca Stories
FREMONT, Calif., Dec. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enroll more than 1,500 patients in 15 countries INDIANAPOLIS, Dec.
DALLAS, November 28, 2014 /PRNewswire/ -- ReportsnReports.com adds PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 research report that says asthma
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo THOUSAND OAKS, Calif. and LONDON, Nov.
ALTON, Ill., Nov.
Global Schizophrenia Therapeutics Market 2014-2018 is a new industry research report, of 102 Pages profiles key players like AstraZeneca plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F.
BASEL, Switzerland, Nov.
Farmers, Agribusinesses Have Begun Filing Syngenta Lawsuits Alleging Syngenta Inc.’s Attempts to Commercial Agrisure Viptera and Other GMO Corn Seed Products Has Ruined the Market for U.S.
- To swell, as grain or wood with water.